Christopher R. Cogle, M.D. is a professor of medicine at the University of Florida and Chief Medical Officer for Florida’s Agency for Health Care Administration. Internationally recognized for discovering the vascular niche as a sanctuary site for leukemia and the plasticity of adult blood stem cells, Dr. Cogle has since led pioneering research in oncology and cardiology, directing landmark clinical trials that translated stem cell biology into innovative therapies now shaping modern standards of care. He is the founding director of the Florida Health Policy Leadership Academy, which builds leadership capacity in communities to improve population health. As Chief Medical Officer, he directs statewide strategies that align financing models, clinical quality, graduate medical education, and innovation to improve outcomes for more than millions of Floridians. An accomplished scholar and entrepreneur, Dr. Cogle has authored over 150 peer-reviewed publications, delivered national and international presentations on the intersection of science and policy, and holds multiple patents underlying companies he founded to advance patient care. His work has been recognized by the Harvard Business School, the National Association of Medicaid Directors, the Leukemia & Lymphoma Society, and the American Cancer Society. In addition to leading an internationally distinguished cancer clinic, he has been honored as a Fellow of the Milbank Memorial Fund and Fellow of the National Academy of Medicine’s Emerging Leaders in Health and Medicine program.